We are live on !
Find out more
BC
Banced Corp Portfolio holdings
AUM
$46.1M
Turnover
26.55%
1-Year Est. Return
5.21%
This Fund
S&P 500
This Quarter Est. Return
+2.64%
1 Year Est. Return
-5.21%
3 Year Est. Return
+27.49%
5 Year Est. Return
+51.43%
10 Year Est. Return
–
AUM
$96.1M
AUM Growth
-$3.24M
(-3.3%)
Cap. Flow
-$4.73M
Cap. Flow % of AUM
Cap. Flow %
-4.92%
Top 10 Holdings %
Top 10 Hldgs %
14.67%
Holding
227
New
46
Increased
46
Reduced
99
Closed
33
Avg Time Held
0.5
years
Top 10 Avg Time Held
0.6
years
Top 20 Avg Time Held
0.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Williams Companies
WMB
|
+$756K |
| 2 |
Regeneron Pharmaceuticals
REGN
|
+$512K |
| 3 |
Hartford Financial Services
HIG
|
+$495K |
| 4 |
RFMD
RF MICRO DEVICES INC
RFMD
|
+$495K |
| 5 |
Capital One
COF
|
+$485K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Coca-Cola
KO
|
+$1.07M |
| 2 |
General Mills
GIS
|
+$873K |
| 3 |
Aflac
AFL
|
+$792K |
| 4 |
AT&T
T
|
+$716K |
| 5 |
ExxonMobil
XOM
|
+$559K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.55% |
| 2 | Healthcare | 16.28% |
| 3 | Technology | 12.89% |
| 4 | Industrials | 11.31% |
| 5 | Consumer Discretionary | 11.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Apple
AAPL
$5.07T
| $2.32M | 2.41% |
120,876
+9,492
| +9% | +$181K |
2013 Q2
3 quarters
|
|
2
Pfizer
PFE
$171B
| $1.66M | 1.72% |
54,313
+8,633
| +19% | +$257K |
2013 Q2
3 quarters
|
|
3
Intel
INTC
$460B
| $1.47M | 1.53% |
56,956
-6,750
| -11% | -$169K |
2013 Q2
3 quarters
|
|
4
JPMorgan Chase
JPM
$881B
| $1.35M | 1.41% |
22,291
-889
| -4% | -$51.4K |
2013 Q2
3 quarters
|
|
5
American Express
AXP
$212B
| $1.33M | 1.38% |
14,742
-43
| -0.3% | -$3.84K |
2013 Q2
3 quarters
|
|
6
Alphabet (Google) Class C
GOOG
$3.88T
| $1.23M | 1.28% |
44,446
-5,460
| -11% | -$159K |
2013 Q2
3 quarters
|
|
7
GE Aerospace
GE
$296B
| $1.21M | 1.26% |
9,740
-1,544
| -14% | -$191K |
2013 Q2
3 quarters
|
|
8
Gilead Sciences
GILD
$193B
| $1.2M | 1.25% |
16,967
-1,669
| -9% | -$131K |
2013 Q2
3 quarters
|
|
9
Qualcomm
QCOM
$188B
| $1.19M | 1.24% |
15,100
-5,972
| -28% | -$450K |
2013 Q2
3 quarters
|
|
|
COV
10
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
| $1.14M | 1.19% |
15,541
+1,925
| +14% | +$134K |
2013 Q2
3 quarters
|
|
11
HSBC
HSBC
$310B
| $1.14M | 1.18% |
25,957
+3,982
| +18% | +$181K |
2013 Q2
3 quarters
|
|
12
Altria Group
MO
$124B
| $1.1M | 1.14% |
29,343
-4,295
| -13% | -$156K |
2013 Q2
3 quarters
|
|
13
Magna International
MGA
$17.1B
| $1.01M | 1.05% |
20,912
+2,574
| +14% | +$114K |
2013 Q2
3 quarters
|
|
14
Comcast
CMCSA
$80.5B
| $1M | 1.04% |
40,100
+254
| +0.6% | +$6.62K |
2013 Q2
3 quarters
|
|
15
Starbucks
SBUX
$115B
| $977K | 1.02% |
26,624
+1,102
| +4% | +$40.8K |
2013 Q2
3 quarters
|
|
16
Ford
F
$46.3B
| $966K | 1.01% |
61,958
+745
| +1% | +$11.5K |
2013 Q2
3 quarters
|
|
17
DELISTED
EMC CORPORATION
EMC
| $908K | 0.94% |
33,132
-6,452
| -16% | -$168K |
2013 Q2
3 quarters
|
|
|
ESRX
18
DELISTED
Express Scripts Holding Company
ESRX
| $906K | 0.94% |
12,068
-1,632
| -12% | -$122K |
2013 Q2
3 quarters
|
|
19
Procter & Gamble
PG
$374B
| $899K | 0.94% |
11,160
+4,283
| +62% | +$337K |
2013 Q2
3 quarters
|
|
20
McKesson
MCK
$117B
| $868K | 0.9% |
4,917
+525
| +12% | +$91.7K |
2013 Q2
3 quarters
|
|
21
Chevron
CVX
$457B
| $862K | 0.9% |
7,249
-1,717
| -19% | -$200K |
2013 Q2
3 quarters
|
|
22
Delta Air Lines
DAL
$50.5B
| $856K | 0.89% |
24,695
+10,056
| +69% | +$323K |
2013 Q2
3 quarters
|
|
23
DELISTED
Walgreens Boots Alliance
WBA
| $839K | 0.87% |
12,712
-1,854
| -13% | -$117K |
2013 Q2
3 quarters
|
|
24
Norfolk Southern
NSC
$74.1B
| $826K | 0.86% |
8,501
-1,446
| -15% | -$134K |
2013 Q2
3 quarters
|
|
25
Conagra Brands
CAG
$7.09B
| $824K | 0.86% |
34,136
+12,195
| +56% | +$293K |
2013 Q2
3 quarters
|
|
Similar funds
DE
CCM
Banced Corp's Q1 2014 Portfolio in Review
As of Q1 2014, Banced Corp held 227 positions worth $96.1M, down 3.3% from $99.4M the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Banced Corp withdrew a net $4.73M in Q1 2014, closing 33 positions and reducing 99 holdings. Its most notable exit was Coca-Cola, an estimated $1.07M position sold in full.
By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 16% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Banced Corp opened a new position in Williams Companies worth $758K.
- Banced Corp's largest Q1 2014 buy was Williams Companies: 18,668 shares worth $758K.
- Banced Corp added most to Regeneron Pharmaceuticals in Q1 2014, an estimated $512K increase.
- Banced Corp's biggest Q1 2014 reduction was Aflac, cutting an estimated $792K.
- Banced Corp fully exited Coca-Cola in Q1 2014, selling an estimated $1.07M.
- Banced Corp's ten largest holdings make up 15% of its $96.1M portfolio in Q1 2014.
- Banced Corp opened 46 new positions and closed 33 in Q1 2014.
- Banced Corp's portfolio value fell 3.3% quarter-over-quarter to $96.1M.
Based on Banced Corp's 13F filing for Q1 2014, filed 14 Apr 2014.